hsa-mir-6744-3p _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018493
Fusion event
HBV-NOA1 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1633
Integrated sequence
CTCTTTACGCGGACTCCCCGTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCAC| |CAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACT
Host Sequence
Chromosome
chr4
Cytoband
q12
Reference genome
End
57834683/56968517 (Hg38)
Location type
Intron4
Fragile sites / regions
Target gene
miRNAs that regulate target gene
hsa-mir-197-3p ; hsa-mir-6780a-5p ; hsa-mir-6779-5p ; hsa-mir-3689c ; hsa-mir-3689b-3p ; hsa-mir-3689a-3p ; hsa-mir-1273h-5p ; hsa-mir-30b-3p ; hsa-mir-1273e ; hsa-mir-4451 ; hsa-mir-6799-5p ; hsa-mir-6883-5p ; hsa-mir-6785-5p ; hsa-mir-4728-5p ; hsa-mir-149-3p ; hsa-mir-7106-5p ; hsa-mir-6894-5p ; hsa-mir-4722-5p ; hsa-mir-98-5p ; hsa-mir-4500 ; hsa-mir-4458 ; hsa-let-7i-5p ; hsa-let-7g-5p ; hsa-let-7f-5p ; hsa-let-7e-5p ; hsa-let-7d-5p ; hsa-let-7c-5p ; hsa-let-7b-5p ; hsa-let-7a-5p ; hsa-mir-1827 ; hsa-mir-3192-5p ; hsa-mir-4649-3p ; hsa-mir-4459 ; hsa-mir-6831-5p ; hsa-mir-3927-3p ; hsa-mir-940 ; hsa-mir-6893-5p ; hsa-mir-6808-5p ; hsa-mir-7851-3p ; hsa-mir-490-3p ; hsa-mir-5010-3p ; hsa-mir-2113 ; hsa-mir-6855-5p ; hsa-mir-3170 ; hsa-mir-411-5p ; hsa-mir-4775 ; hsa-mir-6832-5p ; hsa-mir-193b-5p ; hsa-mir-1273f ; hsa-mir-4735-5p ; hsa-mir-6890-5p ; hsa-mir-590-3p ; hsa-mir-655-5p ; hsa-mir-640 ; hsa-mir-378a-5p ; hsa-mir-4436b-5p ; hsa-mir-6821-3p ; hsa-mir-4312 ; hsa-mir-3653-5p ; hsa-mir-6790-3p ; hsa-mir-3934-5p ; hsa-mir-764 ; hsa-mir-125a-3p ; hsa-mir-6878-3p ; hsa-mir-6744-3p ; hsa-mir-4757-5p ; hsa-mir-6778-3p ; hsa-mir-212-5p ; hsa-mir-548s ; hsa-mir-4684-5p ; hsa-mir-3926 ; hsa-mir-4786-5p ; hsa-mir-3190-5p ; hsa-mir-6849-3p ; hsa-mir-548o-3p ; hsa-mir-1323 ; hsa-mir-3675-3p ; hsa-mir-374c-3p ; hsa-mir-6771-3p ; hsa-mir-5582-3p ; hsa-mir-548c-3p ; hsa-mir-7156-3p ; hsa-mir-1184 ; hsa-mir-4726-3p ; hsa-mir-6764-5p ; hsa-mir-1915-3p ; hsa-mir-6840-3p ; hsa-mir-484 ; hsa-mir-3155b ; hsa-mir-4733-5p ; hsa-mir-3155a ; hsa-mir-509-5p ; hsa-mir-509-3-5p ; hsa-mir-4418
Nearest miRNA
hsa-mir-12113/Upstream/4255767; hsa-mir-1243/Downstream/3954102;
Upstream sequence
TTACATACTCATTTTGCAGTATATTGAGCTGGTCAAgtgcaagccccgagccttggcagcttccatgtgtaccctgcaaagccacagggtctgagctccc
Downstream sequence
GTGAAGCAAATGGCAGATTTTTAAGAAAATACTTTTATTGAAAATATGATATATTATGATTTACCCGTAAAATAAAAAGTGATGAAAAATATGCCAGACT
Target sequence
TCT
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate